Cognition Therapeutics (CGTX) EBT (2020 - 2026)
Cognition Therapeutics (CGTX) posted quarterly EBT of -$8.9 million for Q1 2026, up 35.89% year-over-year from -$6.5 million in Q1 2025, and up 35.4% quarter-over-quarter from -$13.7 million in Q4 2025.
Cognition Therapeutics (CGTX) EBT (2020 - 2026) Analysis & Trends
Cognition Therapeutics (CGTX) has reported EBT for 7 consecutive years, with -$8.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT rose 35.89% year-over-year to -$8.9 million; the TTM figure through Mar 2026 stood at -$43.8 million (up 21.04% YoY), while the FY2025 annual figure was -$83.8 million, down 146.75% from the prior year.
- EBT rose to -$8.9 million in Q1 2026 per CGTX's latest filing, from -$13.7 million in the prior quarter.
- Across five years, EBT topped out at -$3.7 million in Q1 2022 and bottomed at -$15.8 million in Q2 2024.
- Historically, EBT has averaged -$11.3 million across 5 years, with a median of -$13.7 million in 2025.
- Annual changes were most pronounced in 2022 — EBT sank 1765.02% — and 2025, when it surged 55.05%.
- Cognition Therapeutics' EBT stood at -$12.3 million in 2022, then fell by 24.32% to -$15.2 million in 2023, then rose by 29.29% to -$10.8 million in 2024, then dropped by 27.34% to -$13.7 million in 2025, then surged by 35.4% to -$8.9 million in 2026.
- Business Quant data shows CGTX's EBT at -$8.9 million in Q1 2026, -$13.7 million in Q4 2025, and -$6.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | Cognition Therapeutics | 86.53 Mn | 86.53 Mn | - | -7.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.35 Mn |
| Mar 31, 2026 | -8.87 Mn |
| Dec 31, 2025 | -13.73 Mn |
| Sep 30, 2025 | -6.80 Mn |
| Jun 30, 2025 | -14.46 Mn |
| Mar 31, 2025 | -13.83 Mn |
| Dec 31, 2024 | -10.78 Mn |
| Sep 30, 2024 | -15.13 Mn |
| Jun 30, 2024 | -15.80 Mn |
| Mar 31, 2024 | -15.62 Mn |
| Dec 31, 2023 | -15.24 Mn |
| Sep 30, 2023 | -15.49 Mn |
| Jun 30, 2023 | -4.73 Mn |
| Mar 31, 2023 | -6.17 Mn |
| Dec 31, 2022 | -12.26 Mn |
| Sep 30, 2022 | -14.28 Mn |
| Jun 30, 2022 | -5.88 Mn |
| Mar 31, 2022 | -3.71 Mn |
| Dec 31, 2021 | -11.81 Mn |
| Sep 30, 2021 | -27.44 Mn |